Joan Wood was Resigned as Senior Vice President and Chief Human Resources Officer at Karyopharm

Date of management change: October 15, 2019 

What Happened?

Newton, MA-based Karyopharm Resigned Joan Wood as Senior Vice President and Chief Human Resources Officer

 

About the Company

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.

 

About the Person

Joan Wood is Senior Vice President and Chief Human Resources Officer at Karyopharm. Previously, Joan held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Tuggle Anthony, Tanaka Mari, Hurst Christa, Billingsly Sharon, Laporte Lisa, Thompson Kristy, Leonardi Gene, Rush Hope, Foster Pamela, Anderson Lauren, Lee Paul

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.